The total weight loss at 12 months for most people falls between 15 and 22% of starting body weight
Some emerging research has explored potential connections between GLP-1 signalling and thyroid function
And for many, they delivered: 10%, 15%, or even 20% body weight lost Lower glucose, blood pressure, and inflammation Fewer heart attacks, as seen in the SELECT trial It felt like medicine had cracked the metabolic code
Tirzepatide combines the incretin effects of GLP-1 with GIP, the latter of which contributes to appetite regulation and further reductions in food intake
Invert the vial so the needle points upward
Management of hyperglycemia in hospitalized adult patients in non-critical care settings: an Endocrine Society Clinical Practice Guideline